Lululemon’s second-quarter earnings were astounding in the current retail context
Q2 should comfort investors worried about how the company will fare amid inflationary and recessionary...
XOM has been the best-performing mega-cap stock of the past 12 months
Higher oil prices have helped — but so have internal improvements
Returns going forward likely won’t match those of...
Harley-Davidson increasingly looks like it was a “pandemic winner”
Earnings across the business look set for a decline
At 9x earnings, HOG seems cheap—but likely remains...
Before GME became the original “meme stock,” it was a deep value play
The stock’s adherents — including two now-famous bulls — saw upside from a turnaround
Q2 earnings...
LCID has dropped 70% since December — and the decline seems overwrought
The company is dealing with short-term challenges, but the long-term outlook remains positive
Yet, valuation remains a key...
From a broad perspective, the story surrounding TLRY stock is delayed, not broken
But subpar execution has been as big a problem as slow regulators
Long term, the stock can still work out, but at the...
MRNA is an exceptionally difficult stock to value, given enormous uncertainty surrounding its COVID-19 vaccine and other drugs in its pipeline
But there is a case that an enterprise value still over...
DOLE’s initial public offering last year was poorly received, and the stock now is threatening all-time lows
In the context of inflation and execution missteps, the stock’s valuation looks...
Peloton's fundamentals are awful and suggest a high likelihood of near-term bankruptcy
The company is working to improve its situation, and some of the strategic moves may well work
But two key...
History shows that volatility in AMD stock is no surprise
Recent developments have spooked investors
But a rebound seems likely
On Nov. 29 of last year, Advanced Micro Devices (NASDAQ:AMD) stock set...